Change in medical spending attributable to diabetes: National data from 1987 to 2011

Diabetes Care

Volumn 38, Issue 4, 2015, Pages 581-587

  Zhuo, Xiaohui ^a   Zhang, Ping ^a   Kahn, Henry S ^a   Bardenheier, Barbara H ^a   Li, Rui ^a   Gregg, Edward W ^a  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL PEPTIDASE IV INHIBITOR; GLITAZONE DERIVATIVE; INCRETIN; METFORMIN; SULFONYLUREA DERIVATIVE;

ADULT; ARTICLE; CONTROLLED STUDY; DIABETES CARE; DIABETES MELLITUS; DRUG COST; EMERGENCY CARE; FEMALE; HEALTH CARE COST; HEALTH SURVEY; HOME CARE; HOSPITAL ADMISSION; HOSPITAL CARE; HOSPITAL COST; HUMAN; INSTITUTIONAL CARE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL SERVICE; MORBIDITY; OUTPATIENT CARE; PATIENT CARE; PRESCRIPTION; TREND STUDY; AMBULATORY CARE; ECONOMICS; EPIDEMIOLOGY; HOSPITALIZATION; INFORMATION PROCESSING; MIDDLE AGED; STATISTICS AND NUMERICAL DATA; TIME; TRENDS; UNITED STATES; YOUNG ADULT;

ADULT; AMBULATORY CARE; DATA COLLECTION; DIABETES MELLITUS; FEMALE; HEALTH CARE COSTS; HEALTH EXPENDITURES; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; TIME FACTORS; UNITED STATES; YOUNG ADULT;

EID: 84928647672     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc14-1687     Document Type: Article

References (31)

1. Centers for Disease Prevention and Control. Percentage of civilian, noninstitutionalized population with diagnosed diabetes, by age, United States, 1980-2010 [article online], 2011. Available from http://www.cdc.gov/diabetes/statistics/prev/national/figbyage.htm. Accessed 12 June 2013.
2. Grant RW, Pirraglia PA, Meigs JB, Singer DE. Trends in complexity of diabetes care in the United States from 1991 to 2000. Arch Intern Med 2004;164:1134-1139.
3. United Kingdom Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-853.
4. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulindependent diabetes mellitus. N Engl J Med 1993;329:977-986.
5. United Kingdom Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998;317:703-713.
6. Fowler M. Microvascular and macrovascular complications of diabetes. Clin Diabetes 2008; 26:77-82.
7. American Diabetes Association. Standards of medical care in diabetesd2013. Diabetes Care 2013;36(Suppl. 1):S11-S66.
8. Wysowski DK, Armstrong G, Governale L. Rapid increase in the use of oral antidiabetic drugs in the United States, 1990-2001. Diabetes Care 2003;26:1852-1855.
9. Alexander GC, Sehgal NL, Moloney RM, Stafford RS. National trends in treatment of type 2 diabetes mellitus, 1994-2007. Arch Intern Med 2008;168:2088-2094.
10. Turner LW, Nartey D, Stafford RS, Singh S, Alexander GC. Ambulatory treatment of type 2 diabetes in the U.S., 1997-2012. Diabetes Care 2014;37:985-992.
11. Zuvekas SH, Cohen JW. A guide to comparing health care expenditures in the 1996 MEPS to the 1987 NMES. Inquiry 2002;39:76-86.
12. Manning WG, Mullahy J. Estimating log models: to transform or not to transform? J Health Econ 2001;20:461-494.
13. Greene W. Accounting for excess zeros and sample selection in poisson and negative binomial regression modelsa: NYU Working Paper No. EC-94-10 [article online], 1994. Available from http://papers.ssrn.com/sol3/papers.cfm?abstract-id=1293115## Accessed 1 June 2013.
14. Honeycutt AA, Segel JE, Hoerger TJ, Finkelstein EA. Comparing cost-of-illness estimates fromalternative approaches: An application to diabetes. Health Serv Res 2009;44:303-320.
15. Lee DW, Meyer JW, Clouse J. Implications of controlling for comorbid conditions in cost-ofillness estimates: A case study of osteoarthritis from a managed care systemperspective. Value Health 2001;4:329-334.
16. Deeb CL. Diabetes technology during the past 30 years: A lot of changes and mostly for the better. Diabetes Spectrum 2008;21:78-83.
17. American Diabetes Association. Economic consequences of diabetes mellitus in the U.S. in 1997. Diabetes Care 1998;21:296-309.
18. Hogan P, Dall T, Nikolov P; American Diabetes Association. Economic costs of diabetes in the US in 2002. Diabetes Care 2003;26:917-932.
19. American Diabetes Association. Economic costs of diabetes in the U.S. In 2007. Diabetes Care 2008;31:596-615.
20. American Diabetes Association. Economic costs of diabetes in the U.S. in 2012. Diabetes Care 2013;36:1033-1046.
21. Roehrig CS, Rousseau DM. The growth in cost per case explains far more of US health spending increases than rising disease prevalence. Health Aff (Millwood) 2011;30:1657-1663.
22. Henry J. Kaiser Family Foundation. Prescription drug trends fact sheetd May 2010 update [Internet], 2010. Menlo Park, CA: Henry J. Kaiser Family Foundation. Available from http://kff.org/health-costs/fact-sheet/prescription-drug-trendsfact-sheet-may-2010/Accessed 5 June 2013.
23. Stephens JM, BottemanMF, Hay JW. Economic impact of antidiabetic medications and glycemiccontrol on managed care organizations: A review of the literature. J Manag Care Pharm 2006;12:130- 142.
24. Cohen FJ, Neslusan CA, Conklin JE, Song X. Recent antihyperglycemic prescribing trends for US privately insured patients with type 2 diabetes. Diabetes Care 2003;26:1847- 1851.
25. Lemieux J, Mulligan T. Trends in inpatient hospital prices, 2008 to 2010. Am J Manag Care 2013;19:e106-e113.
26. Maeda JL, Raetzman SO, Friedman BS. What hospital inpatient services contributed the most to the 2001-2006 growth in the cost per case? Health Serv Res 2012;47:1814-1835.
27. Gregg EW, Li Y, Wang J, et al. Changes in diabetes-related complications in theUnited States, 1990-2010. N Engl J Med 2014;370:1514-1523.
28. Wang J, Geiss LS, Cheng YJ, et al. Long-term and recent progress in blood pressure levels among U.S. adults with diagnosed diabetes, 1988-2008. Diabetes Care 2011;34:1579-1581.
29. Ali MK, Bullard KM, Saaddine JB, Cowie CC, Imperatore G, Gregg EW. Achievement of goals in U.S. diabetes care, 1999-2010. N Engl J Med 2013;368:1613-1624.
30. Hoerger TJ, Segel JE, Gregg EW, Saaddine JB. Is glycemic control improving in U.S. adults? Diabetes Care 2008;31:81-86.
31. Zuvekas SH, Olin GL. Validating household reports of health care use in the Medical Expenditure Panel Survey. Health Serv Res 2009;44: 1679-1700.